Capstar Special Purpose Acquisition Corp - Ordinary Shares - Class A

NYSE:CPSR   3:59:10 PM EDT
9.85
+0.02 (+0.20%)
Debt Financing / Related, Exchange Changes, Mergers / Acquisitions

Gelesis, A Consumer-Focused Biotherapeutics Company And The Maker Of Plenity®, To Become A Publicly Traded Company Via Merger With Capstar Special Purpose Acquisition Corp.

Published: 07/19/2021 13:02 GMT
Capstar Special Purpose Acquisition Corp - Ordinary Shares - Class A (CPSR) - Gelesis, a Consumer-focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company Via Merger With Capstar Special Purpose Acquisition Corp.
Capstar Special Purpose Acquisition Corp - Pro Forma Implied Market Value of About $1.3 Billion and Enterprise Value of About $1.0 Billion.
Capstar Special Purpose Acquisition - Upon Completion of Deal, Combined Co's Securities Expected to Be Traded on Nyse Under Symbol "gls".
Capstar Special Purpose Acquisition Corp - Transaction is Expected to Provide Gelesis With Up to $376 Million of Gross Proceeds.
Capstar Special Purpose Acquisition - Pipe Financing Anchored by Investors, Partners, Including Pimco Private Funds, Pritzker Vlock Family Office, Puretech Health.